Building the Evidence Base That Connects Innovation to Patient Access
Innovation in medicine has never been more rapid. Gene therapies, targeted biologics, digital therapeutics, and precision oncology treatments are expanding what is clinically possible at a remarkable pace. But clinical possibility alone does not guarantee patient access. Between the laboratory and the patient lies a demanding landscape of economic scrutiny, reimbursement negotiation, and...
0 Commentarios 0 Acciones 0 Vista previa